Heidar, M., Metwally, I., Taha, T. (2017). Magnetic Resonance Spectroscopy in Evaluation of Multiple Sclerosis. The Egyptian Journal of Hospital Medicine, 69(1), 1748-1756. doi: 10.12816/0040141
Mustafa Al Hassan Abdou Heidar; Iman Soliman Metwally; Tougan Taha. "Magnetic Resonance Spectroscopy in Evaluation of Multiple Sclerosis". The Egyptian Journal of Hospital Medicine, 69, 1, 2017, 1748-1756. doi: 10.12816/0040141
Heidar, M., Metwally, I., Taha, T. (2017). 'Magnetic Resonance Spectroscopy in Evaluation of Multiple Sclerosis', The Egyptian Journal of Hospital Medicine, 69(1), pp. 1748-1756. doi: 10.12816/0040141
Heidar, M., Metwally, I., Taha, T. Magnetic Resonance Spectroscopy in Evaluation of Multiple Sclerosis. The Egyptian Journal of Hospital Medicine, 2017; 69(1): 1748-1756. doi: 10.12816/0040141
Magnetic Resonance Spectroscopy in Evaluation of Multiple Sclerosis
Department of Radio Diagnosis, Faculty of Medicine, Ain Shams University
Abstract
MS is a diffuse immune-mediated inflammatory disease that evolves over time; it’s characterized by the presence of CNS lesions disseminated in space and time. Plaques of inflammatory demyelination within the CNS are the pathologic hallmark of MS. 1H-MRS is a noninvasive imaging technique that’s promising as diagnostic technique for MS as well as a good marked for immune-modularity therapy response and as a predictor for clinical disability in MS. Aim of the Study: To highlight the value of MR spectroscopy in evaluation & monitoring patients with multiple sclerosis and how MR spectroscopy can add valuable information to conventional MR.